NDC 62332-332 – Carbidopa and Levodopa

Carbidopa 25 mg/1; Levodopa 100 mg/1 · Tablet, Extended Release · Oral

Human Prescription Drug

Product NDC62332-332

Product details

Brand name
Carbidopa and Levodopa
Generic name
Carbidopa and Levodopa
Labeler
Alembic Pharmaceuticals Inc.
Dosage form
Tablet, Extended Release
Route
Oral
Marketing category
ANDA · ANDA210341
Marketed since
June 6, 2019
Listing expires
December 31, 2027
Pharmacologic class
Aromatic Amino Acid

Active ingredients

Uses, dosage, side effects and warnings for Carbidopa and Levodopa →

Package NDC codes (3)

Package NDCDescriptionSince
62332-332-3030 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-30)Jun 6, 2019
62332-332-31100 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-31)Jun 6, 2019
62332-332-911000 TABLET, EXTENDED RELEASE in 1 BOTTLE (62332-332-91)Jun 6, 2019

Other Carbidopa and Levodopa products